AU5495798A - External preparations for percutaneous absorption - Google Patents
External preparations for percutaneous absorptionInfo
- Publication number
- AU5495798A AU5495798A AU54957/98A AU5495798A AU5495798A AU 5495798 A AU5495798 A AU 5495798A AU 54957/98 A AU54957/98 A AU 54957/98A AU 5495798 A AU5495798 A AU 5495798A AU 5495798 A AU5495798 A AU 5495798A
- Authority
- AU
- Australia
- Prior art keywords
- percutaneous absorption
- external preparations
- preparations
- external
- percutaneous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9-5516 | 1997-01-16 | ||
JP551697 | 1997-01-16 | ||
JP9-72294 | 1997-03-25 | ||
JP7229497 | 1997-03-25 | ||
JP9-347999 | 1997-12-17 | ||
JP34799997 | 1997-12-17 | ||
PCT/JP1998/000123 WO1998031369A1 (en) | 1997-01-16 | 1998-01-16 | External preparations for percutaneous absorption |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5495798A true AU5495798A (en) | 1998-08-07 |
Family
ID=27276790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU54957/98A Abandoned AU5495798A (en) | 1997-01-16 | 1998-01-16 | External preparations for percutaneous absorption |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU5495798A (en) |
WO (1) | WO1998031369A1 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2475573C (en) | 2002-02-11 | 2013-03-26 | Antares Pharma, Inc. | Intradermal injector |
ES2908027T3 (en) | 2005-01-24 | 2022-04-27 | Antares Pharma Inc | An injector with a pre-filled syringe |
WO2007131025A1 (en) | 2006-05-03 | 2007-11-15 | Antares Pharma, Inc. | Injector with adjustable dosing |
US8251947B2 (en) | 2006-05-03 | 2012-08-28 | Antares Pharma, Inc. | Two-stage reconstituting injector |
US8814834B2 (en) | 2008-03-10 | 2014-08-26 | Antares Pharma, Inc. | Injector safety device |
JP5611208B2 (en) | 2008-08-05 | 2014-10-22 | アンタレス・ファーマ・インコーポレーテッド | Multiple dose injection device |
JP5732039B2 (en) | 2009-03-20 | 2015-06-10 | アンタレス・ファーマ・インコーポレーテッド | Hazardous drug injection system |
US8491927B2 (en) | 2009-12-02 | 2013-07-23 | Nimble Epitech, Llc | Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor |
US8496619B2 (en) | 2011-07-15 | 2013-07-30 | Antares Pharma, Inc. | Injection device with cammed ram assembly |
US9220660B2 (en) | 2011-07-15 | 2015-12-29 | Antares Pharma, Inc. | Liquid-transfer adapter beveled spike |
PT2822618T (en) | 2012-03-06 | 2024-03-04 | Antares Pharma Inc | Prefilled syringe with breakaway force feature |
US9950125B2 (en) | 2012-04-06 | 2018-04-24 | Antares Pharma, Inc. | Needle assisted jet injection administration of testosterone compositions |
WO2013169804A1 (en) | 2012-05-07 | 2013-11-14 | Antares Pharma, Inc. | Needle assisted jet injection device having reduced trigger force |
EP2953667B1 (en) | 2013-02-11 | 2019-10-23 | Antares Pharma, Inc. | Needle assisted jet injection device having reduced trigger force |
SG11201507117XA (en) | 2013-03-06 | 2015-10-29 | Janssen Pharmaceutica Nv | Benzoimidazol-2-yl pyrimidine modulators of the histamine h4 receptor |
EP3572108A1 (en) | 2013-03-11 | 2019-11-27 | Antares Pharma, Inc. | Dosage injector with pinion system |
WO2014165136A1 (en) | 2013-03-12 | 2014-10-09 | Antares Pharma, Inc. | Constant volume prefilled syringes and kits thereof |
US20190343796A1 (en) * | 2016-12-28 | 2019-11-14 | Fujifilm Toyama Chemical Co., Ltd. | Composition for external use |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0247900B1 (en) * | 1986-05-30 | 1991-12-18 | The Regents Of The University Of California | Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease |
CA2262009A1 (en) * | 1996-07-23 | 1998-01-29 | Wilson T. Crandall | Transdermal transport of molecules |
-
1998
- 1998-01-16 AU AU54957/98A patent/AU5495798A/en not_active Abandoned
- 1998-01-16 WO PCT/JP1998/000123 patent/WO1998031369A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1998031369A1 (en) | 1998-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6122999A (en) | Sorbefacients and preparations for percutaneous absorption containing the same | |
AU1151099A (en) | Azaoxindole derivatives | |
AU1825899A (en) | Dota-biotin derivatives | |
AU7935398A (en) | Diaminorhodamine derivatives | |
AUPM434594A0 (en) | Canopy | |
AU6117998A (en) | 3-oxadiazolylquinoxaline derivatives | |
AU5495798A (en) | External preparations for percutaneous absorption | |
AU7069198A (en) | Collimator | |
AUPO688997A0 (en) | Sunscreen composition | |
AU6804098A (en) | Triazinylaminostilbene compounds | |
AU9663498A (en) | Sunscreen composition | |
AU3089199A (en) | Preparations containing licariin | |
EP1221315A4 (en) | Ophthalmic adhesive preparations for percutaneous absorption | |
AU3536799A (en) | Percutaneous preparations containing oxybutynin | |
AU4330097A (en) | Pharmaceutical compounds | |
AU7813598A (en) | Betulinol derivatives | |
EP0968710A4 (en) | Patch preparations for percutaneous absorption | |
AU7124598A (en) | Polymer-platinum compounds | |
AUPP042397A0 (en) | 5-arylpyrazole compounds | |
AU1174199A (en) | Biphenylamidine derivatives | |
AU6729498A (en) | Thiazolimine derivatives | |
AU4169897A (en) | Pharmaceutical compounds | |
AU1800100A (en) | Medicinal preparations | |
AU8019998A (en) | Fluoromethoximino compounds | |
AU6115798A (en) | Saponarin derivatives |